Company Overview
About Outpace Bio
Outpace Bio is a clinical-stage biotechnology company headquartered in Seattle, Washington, founded to address one of the most significant unmet needs in oncology: creating effective cell therapies for solid tumors. While CAR-T cell therapies have transformed treatment of blood cancers, they have largely failed against solid tumors due to the immunosuppressive tumor microenvironment, T-cell exhaustion, and tumor heterogeneity. Outpace Bio applies AI-powered protein design and synthetic biology to engineer novel cellular logic circuits — custom genetic programs embedded in therapeutic T cells — that allow the cells to sense the tumor environment and respond adaptively rather than becoming exhausted or suppressed.
Business Model & Competitive Advantage
The company's platform is built on genetic "circuit" technology: engineered T cells that carry synthetic regulatory programs controlling their activation, persistence, and function based on environmental signals within the tumor. This approach, inspired by computational systems biology, allows Outpace to design cells that behave more like intelligent agents — capable of sustained activity in hostile environments — than conventional engineered T cells. Outpace Bio raised a $109M Series B in 2024, with investors including Andreessen Horowitz Bio, Arch Venture Partners, and other leading life sciences funds. The company was founded by researchers and executives with backgrounds in CAR-T therapy development and computational protein engineering.
Competitive Landscape 2025–2026
Outpace Bio operates in the advanced cell therapy sector alongside companies like Lyell Immunopharma, Tmunity (acquired by Kite/Gilead), A2 Biotherapeutics, and Senti Biosciences — all working to crack the solid tumor barrier for cell therapies. Its differentiation lies in the combination of AI-assisted protein design for novel therapeutic circuit components and its systems biology-driven approach to cell programming. The company's pipeline targets multiple solid tumor indications including colorectal, ovarian, and lung cancers.
Key Differentiators
Emerging Innovator
Outpace Bio is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Outpace Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Outpace Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Outpace Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Outpace Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →